Collegium Pharma Inc. (coll 2.875 02/15/29)
13F holders, Q1 2024 (March 31)1holders
$1278.64avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Collegium Pharma Inc. (coll 2.875 02/15/29) in their 13F filings. The largest holder was Boussard & Gavaudan Investment Management LLP ($7.7M).
- Company
- Collegium Pharma Inc. (coll 2.875 02/15/29)
- CUSIP
- 19459JAC8
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $7.7M |
| Exits | 0 | $0 |
Ownership 1 holders
| Boussard & Gavaudan Investment Management LLP | 1.40% | New | 6,000 | $7.7M |
"% of holder's portfolio" is COLLEGIUM PHARMA INC (COLL 2.875 02/15/29)'s weight in each manager's 13F, not the share of Collegium Pharma Inc. (coll 2.875 02/15/29) the manager owns.